HealthCare Global Enterprises Limited has announced the opening of a special window for transfer and dematerialization of physical securities, providing shareholders with a one-year opportunity to process their physical share holdings. This initiative represents a significant regulatory compliance measure following recent SEBI guidelines.

Special Window Details

The special window will remain operational from February 05, 2026 to February 04, 2027, spanning exactly one year. This facility has been established in accordance with SEBI circular no. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. The window specifically caters to physical securities that were sold or purchased prior to April 01, 2019.

Eligibility Criteria

The company has provided clear guidelines regarding eligibility for lodgement during this special window:

Processing Requirements

Requests submitted during the special window must include original certificate(s) along with transfer deeds and relevant supporting documents. All securities transferred through this facility will be mandatorily credited to transferees in demat mode only. Additionally, these transferred securities will remain in lock-in for one year from the transfer registration date, during which they cannot be transferred, pledged, or encumbered.

Shareholder Assistance

Shareholders wishing to avail this opportunity are requested to contact KFin Technologies Limited, the company's Registrar and Share Transfer Agent. The registrar can be reached at inward.ris@kfintech.com or through the toll-free number 1800-309-4001. KFin Technologies Limited is located at Selenium Tower-B, Plot No. 31 and 32, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad, Telangana, India - 500032.

Regulatory Compliance

HealthCare Global Enterprises Limited has fulfilled its regulatory obligations by publishing newspaper advertisements in Business Standard (English) and Vijayawani (Kannada) as required under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's stock codes are BSE – 539787 and NSE – HCG. Additional information regarding this special window is available on the company's website at https://www.hcgoncology.com/ .

HealthCare Global Enterprises Limited has successfully completed the allotment of equity shares under its rights issue and published the mandatory advertisement intimation under Regulation 92 of SEBI ICDR Regulations. The Rights Issue Committee meeting held on March 27, 2026, approved the allotment of 82,94,566 equity shares to eligible shareholders and renouncees.

Rights Issue Details

The rights issue was conducted with specific terms that provided existing shareholders the opportunity to subscribe to additional shares. The issue opened on March 11, 2026, and closed on March 25, 2026, giving eligible shareholders a two-week window to participate. The record date for determining eligible shareholders was set as March 02, 2026.

Subscription and Allotment Response

The rights issue received an overwhelming response from investors, with total applications for 10,713,388 Rights Equity Shares against the offered 82,94,566 shares. Out of 3,446 total applications, 185 applications for 12,945 shares were rejected due to technical reasons. The final valid applications totaled 3,261 for 10,700,443 Rights Equity Shares, representing 129.01% subscription of the offered shares.

Capital Structure Impact

The successful completion of the rights issue has resulted in a substantial increase in the company's paid-up equity share capital. The allotment has enhanced the company's capital base from ₹141,00,76,370 to ₹149,30,22,030, providing additional financial resources for its operations and growth initiatives.

Regulatory Compliance and Advertisement Publication

On March 30, 2026, the company published advertisements in compliance with Regulation 92 of SEBI ICDR Regulations in Financial Express (English national daily), Jansatta (Hindi national daily), and Vishwavani (Kannada daily newspaper). The advertisement detailed subscription information, basis of allotment, and credit dates for equity shares. The company has fulfilled all regulatory requirements under SEBI Master Circular and disclosed necessary information as prescribed.

Trading Commencement

The dispatch of allotment advice and unblocking intimation to investors was completed after executing corporate action for crediting equity shares into respective demat accounts on March 30, 2026. Trading in fully paid-up equity shares issued in the rights issue is expected to commence on April 1, 2026, subject to receipt of listing and trading permissions from NSE and BSE.

The rights issue represents a strategic move by HealthCare Global Enterprises to strengthen its financial position and support future business objectives. The successful completion demonstrates strong investor confidence in the company's prospects and management's ability to execute capital raising initiatives effectively.